The NSW Court of Appeal has rejected all grounds of appeal brought by Cosette Pharmaceuticals, Inc in its attempt to establish it had a right to terminate the scheme implementation deed with Mayne Pharma Group Limited, reinforcing that the threshold for proving a MAC involves a high standard.
In brief
The NSW Court of Appeal has rejected all grounds of appeal brought by Cosette Pharmaceuticals, Inc (Cosette) in its attempt to establish it had a right to terminate the scheme implementation deed with Mayne Pharma Group Limited (Mayne).
The Court of Appeal’s decision makes clear that:
- The terms of the SID are the source of truth and Courts will interpret the drafting strictly, and accordingly parties should be very specific in MAC drafting.